The bills we support and why

The Colorado Foundation for Universal Health Care gives FULL SUPPORT to bills that advance universal health care: That means actively promoting the legislation on our website and social media, mobilizing our supporters, providing testimony at committee hearings, sending letters to the editor, and whatever else we can do to move legislation forward.

Anyone who would like to join our team of legislative advocates should contact Judy Burke and Jim Potter:
JudithBurke2@msn.com
jamesraymondpotter@gmail.com

The Foundation’s leadership teams also choose which bills to oppose, monitor, and support.

The Foundation gives limited SUPPORT to legislation that in some way improves aspects of the existing health care system. These are the bills that we:

Fully Support: The Health Care Cost Analysis Act of 2018 will vet various proposals for universal health care. Rep. Edie Hooten will introduce it in the House. Sen. Irene Aguilar, M.D. will introduce it in the Senate. No bill number yet, but we will keep you posted.

Fully Support: Rep. Joe Salazar’s HB18-1179 to Prohibit Price Gouging On Prescription Drugs would allow the Attorney General to roll back unconscionable increases in drug prices of off-patent and generic drugs, putting a stop to this illegal and deceptive trade practice in Colorado.

The Foundation conducted an effective eblast, phone calling, and lobbying campaign. On March 8, the bill passed the Committee on Health, Insurance & Environment by a 7-6 party line vote. On March 15, it passed the finance committee by a 7-6 vote, also along party lines. It’s now in the Appropriations Committee. Then, it’s on to a vote in the House.

Support:
HB18-1207 a bill requiring Hospital Financial Transparency Measures
HB18-1284 a bill requiring Disclosure Of Prescription Costs At Pharmacies
HB18-1260 a bill that would require Prescription Drug Price Transparency

All of these bills are moving along — having narrowly made it out of the House Committee on Health, Insurance & Environment by party-line votes. Although such bills improve price transparency, they do not directly challenge drug price increases by either making them illegal or by introducing a market challenge that would put downward pressure on drug prices.

It seems strange the Republicans on these committees oppose transparency in prices.

Fully Supported:
SB18-080: This excellent bill for a Wholesale Canadian Drug Importation Program would have allowed the 1import of prescription pharmaceuticals from Canada for sale to Colorado consumers. Sponsored by Sen. Irene Aguilar, M.D. and and Rep. Susan Lontine, the bill saw defeat, with Republicans killing it in a party-line vote.

We expect to see this excellent proposal resurface.

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *